SARS-CoV-2 serum viral load and prognostic markers proposal for COVID-19 pneumonia in low-dose radiation therapy treated patients

B Piqué, K Peña, F Riu, JC Acosta… - Journal of clinical …, 2023 - mdpi.com
Several studies have shown that the plasma RNA of SARS-CoV-2 seems to be associated
with a worse prognosis of COVID-19. In the present study, we investigated plasma RNA in …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica, M Merli… - BMC Infectious …, 2021 - Springer
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19

H Kawasuji, Y Morinaga, H Tani… - Journal of Medical …, 2022 - Wiley Online Library
This study aimed to determine the frequency of SARS‐CoV‐2 RNA in serum and its
association with the clinical severity of COVID‐19. This retrospective cohort study performed …

[PDF][PDF] SARS-CoV-2 RNA in plasma is associated with ICU admission and mortality in patients hospitalized with COVID-19

C Prebensen, PLM Hre, C Jonassen, A Rangberg… - Clin Infect …, 2020 - scholar.archive.org
The clinical significance of SARS-CoV-2 RNA in the circulation is unknown. In this
prospective cohort study, we detected viral RNA in the plasma of 58/123 (47%) patients …

Quantitative assessment of SARS‐CoV‐2 RNAemia and outcome in patients with coronavirus disease 2019

K Tang, L Wu, Y Luo, B Gong - Journal of Medical Virology, 2021 - Wiley Online Library
The disease spectrum of coronavirus disease 2019 (COVID‐19) varies from asymptomatic
infection to critical illness and death. Identification of prognostic markers is vital for predicting …

Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis

Y Okita, T Morita, A Kumanogoh - Inflammation and regeneration, 2022 - Springer
Background The duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) RNA positivity will be important to prevent the spread of coronavirus disease 2019 …

Low-dose radiation therapy in the management of coronavirus disease 2019 (COVID-19) pneumonia (LOWRAD-Cov19): Preliminary report

N Sanmamed, P Alcantara, E Cerezo… - International Journal of …, 2021 - Elsevier
Purpose Low-dose radiation therapy (LD-RT) has been shown to have an anti-inflammatory
effect, and preliminary results suggest it is feasible to treat patients with coronavirus disease …

SARS-CoV-2 RNAemia with higher nasopharyngeal viral load is strongly associated with severity and mortality in patients with COVID-19

H Kawasuji, Y Morinaga, H Tani, Y Yoshida… - medRxiv, 2020 - medrxiv.org
Objective This study aimed to determine the frequency of SARS-CoV-2 RNA in serum and its
association with the clinical severity of COVID-19. Methods An analytical cross-sectional …

RNAemia corresponds to disease severity and antibody response in hospitalized COVID-19 patients

KA Eberhardt, C Meyer-Schwickerath, E Heger… - Viruses, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global health
emergency. To improve the understanding of the systemic component of SARS-CoV-2, we …

[HTML][HTML] Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients

M Rizzi, F Patrucco, M Trevisan, G Faolotto… - Panminerva …, 2022 - minervamedica.it
BACKGROUND: SARS-CoV-2 is a single-stranded RNA virus, known to be the causative
agent of COVID-19. As the resulting disease shows a very heterogeneous range of clinical …